These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36877881)

  • 1. Managing Monkeypox Virus: Characterizing Common Cutaneous Manifestations and Antiviral Efficacy.
    Khan M; Rahman S; Ahmed F; Memon N; Haque A
    J Drugs Dermatol; 2023 Mar; 22(3):282-287. PubMed ID: 36877881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monkeypox infection threat: A comprehensive overview.
    Kang Y; Yu Y; Xu S
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011246. PubMed ID: 37079486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
    Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review.
    Kuroda N; Shimizu T; Hirano D; Ishikane M; Kataoka Y
    J Infect Chemother; 2023 Feb; 29(2):228-231. PubMed ID: 36283609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review.
    Webb E; Rigby I; Michelen M; Dagens A; Cheng V; Rojek AM; Dahmash D; Khader S; Gedela K; Norton A; Cevik M; Cai E; Harriss E; Lipworth S; Nartowski R; Groves H; Hart P; Blumberg L; Fletcher T; Jacob ST; Sigfrid L; Horby PW
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35973747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects.
    Imran M; Alshammari MK; Arora MK; Dubey AK; Das SS; Kamal M; Alqahtani ASA; Sahloly MAY; Alshammari AH; Alhomam HM; Mahzari AM; Abida ; Rabaan AA; Dzinamarira T
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive update on the monkeypox outbreak.
    Karim AM; Kwon JE; Karim MA; Iftikhar H; Yasir M; Ullah I; Kang SC
    Front Microbiol; 2022; 13():1037583. PubMed ID: 36439787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mpox in the New York metropolitan area, Summer 2022.
    Gnanaprakasam R; Keller M; Glassman R; El-Khoury MY; Chen DS; Feola N; Feldman J; Chaturvedi V
    J Med Virol; 2023 Apr; 95(4):e28699. PubMed ID: 36951318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission characteristics, replication patterns and clinical manifestations of human monkeypox virus-an in-depth analysis of four cases from Germany.
    Hornuss D; Daehne T; Goetz V; Mueller M; Usadel S; Lorz A; Mockenhaupt M; Huzly D; Bierbaum S; Fuchs J; Jaki L; Falcone V; Kochs G; Panning M; Rieg S
    Clin Microbiol Infect; 2023 Jan; 29(1):112.e5-112.e9. PubMed ID: 36155255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
    Siegrist EA; Sassine J
    Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
    Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
    Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Treatment against Monkeypox: A Scoping Review.
    Ortiz-Saavedra B; León-Figueroa DA; Montes-Madariaga ES; Ricardo-Martínez A; Alva N; Cabanillas-Ramirez C; Barboza JJ; Siddiq A; Coaguila Cusicanqui LA; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Trop Med Infect Dis; 2022 Nov; 7(11):. PubMed ID: 36355910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult.
    Dammann F; Raja M; Camargo JF
    Transpl Infect Dis; 2023 Feb; 25(1):e14022. PubMed ID: 36714983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
    O'Laughlin K; Tobolowsky FA; Elmor R; Overton R; O'Connor SM; Damon IK; Petersen BW; Rao AK; Chatham-Stephens K; Yu P; Yu Y;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1190-1195. PubMed ID: 36107794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Global Human Monkeypox Outbreak and Management: A Comprehensive Literature Review.
    Dighriri IM; Braiji SH; AlAnazi MM; Ayyashi MJ; Khubrani AA; Khormi YB; Shbeir LA; Alatif SI; Alfagih AE
    Cureus; 2022 Dec; 14(12):e32557. PubMed ID: 36654643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
    Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
    J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.